Literature DB >> 3257831

Clinical and experimental study of pancreatic exocrine function after pancreaticoduodenectomy for periampullary carcinoma.

T Tanaka1, Y Ichiba, Y Fujii, O Kodama, K Dohi.   

Abstract

The residual pancreatic exocrine function before and after pancreaticoduodenectomy (PD) for periampullary carcinoma was studied clinically as well as experimentally. In clinical instances (n = 35), the N-Benzoyl-L-Tyrosil-p-Aminobenzoic Acid test (BTPABA test) before and within two months after PD revealed reduction of the function compared with those in the control study. However, the test result one year after PD was improved compared with those before and within two months after operation, without differences from that of the control group. In new canine PD models in which drainage of the pancreatic duct, 50 per cent pancreatectomy and duodenojejunectomy were performed after three months of pancreatic duct obstruction, fibrosis surrounding the pancreatic duct was disclosed. However, the results of examination five months after PD revealed a milder degree of pancreatic fibrosis without aggravation of the lesion. The aforementioned findings indicated that the exocrine pancreas before PD was impaired due to obstructive pancreatitis and that the postoperative pancreatic function was well preserved at the level close to that in the control group even after approximately 50 per cent resection of the pancreas, if pancreatic duct drainage was effectively performed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257831

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  8 in total

1.  Intraoperative radiation enhances decline of pancreatic exocrine function after pancreatic head resection.

Authors:  K Yamaguchi; K Nakamura; M Kimura; K Yokohata; H Noshiro; K Chijiiwa; M Tanaka
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

2.  Which is a less invasive pancreatic head resection: PD, PPPD, or DPPHR?

Authors:  K Yamaguchi; K Yokohata; K Nakano; K Ohtani; Y Ogawa; K Chijiiwa; M Tanaka
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

3.  Experimental study on operative methods of pancreaticojejunostomy with reference to anastomotic patency and postoperative pancreatic exocrine function.

Authors:  Ming-Dong Bai; Liang-Qun Rong; Lian-Chen Wang; Hai Xu; Rui-Fang Fan; Pei Wang; Xiao-Peng Chen; Liu-Bin Shi; Shu-You Peng
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

4.  Short-term and long-term pancreatic exocrine and endocrine functions after pancreatectomy.

Authors:  N Sato; K Yamaguchi; K Yokohata; S Shimizu; T Morisaki; K Chijiiwa; M Tanaka
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

5.  Can we predict postoperative pancreatic leakage after pancreaticoduodenectomy using preoperative fecal elastase-1 level?

Authors:  Hyun Wook Shin; Jae Keun Kim; Joon Seong Park; Dong Sup Yoon
Journal:  J Clin Lab Anal       Date:  2013-09       Impact factor: 2.352

6.  Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy.

Authors:  Hiroyuki Nakamura; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo; Hiroki Ohge; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2009-05-05       Impact factor: 3.452

Review 7.  Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management.

Authors:  Adithya M Pathanki; Joseph A Attard; Elizabeth Bradley; Sarah Powell-Brett; Bobby V M Dasari; John R Isaac; Keith J Roberts; Nikolaos A Chatzizacharias
Journal:  World J Gastrointest Pathophysiol       Date:  2020-04-12

8.  Risk factors deteriorating severe exocrine pancreatic insufficiency measured by stool elastase after pancreatoduodenectomy and the risk factors for weight loss.

Authors:  Ara Cho; Hongbeom Kim; Hee Ju Sohn; Mirang Lee; Yoon Hyung Kang; Hyeong Seok Kim; Youngmin Han; Jae Seung Kang; Wooil Kwon; Jin-Young Jang
Journal:  Ann Surg Treat Res       Date:  2022-01-03       Impact factor: 1.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.